Edition:
United States

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

3.41USD
15 Dec 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.41
Open
$3.41
Day's High
$3.49
Day's Low
$3.33
Volume
50,098
Avg. Vol
23,463
52-wk High
$12.09
52-wk Low
$3.26

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 28.67 -2.668
Jun '17 40.88 -1.152
Mar '17 29.98 -1.670
FY 2016 Dec '16 13.57 -1.482
Sep '16 0.00 -0.562
Jun '16 0.00 -0.485
Mar '16 0.00 -2.072
FY 2015 Dec '15 0.00 -0.348
Sep '15 0.00 -0.254
Jun '15 0.00 -1.038
Mar '15 0.00 -0.575
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 2 32.80 34.00 31.60 0.00
Year Ending Dec-17 2 132.35 133.50 131.20 0.00
Year Ending Dec-18 2 155.00 161.10 148.90 78.50
Earnings (per share)
Quarter Ending Dec-17 2 -1.88 -0.29 -3.47 -0.40
Year Ending Dec-17 1 -8.95 -8.95 -8.95 -2.10
Year Ending Dec-18 2 -3.40 -1.14 -5.67 5.05
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 196.13 36.03
P/E High - Last 5 Yrs. -- 279.92 45.26
P/E Low - Last 5 Yrs. -- 93.48 24.26
Beta 0.32 0.82 0.91
Price to Sales (TTM) 0.56 117.54 5.90
Price to Book (MRQ) 1.66 23.08 5.74
Price to Tangible Book (MRQ) -- 26.92 7.33
Price to Cash Flow (TTM) -- 106.51 24.72
% Owned Institutions 77.31 5.59 1.38

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.02 5.23
Payout Ratio(TTM) -- 98.85 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -4.33 6.77
Sales (TTM) vs TTM 1 Yr. Ago -- 30.49 5.56
Sales - 5 Yr. Growth Rate -- 33.28 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -374.81 -148.85 7.88
EPS (TTM) vs TTM 1 Yr. Ago -101.10 -- --
EPS - 5 Yr. Growth Rate -- 44.44 10.92
Capital Spending - 5 Yr. Growth Rate -45.81 41.25 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.28 1.81 2.55
Current Ratio (MRQ) 1.45 5.63 3.57
LT Debt to Equity (MRQ) 652.75 16.33 13.26
Total Debt to Equity (MRQ) 652.75 18.85 19.22
Interest Coverage (TTM) -2.47 -144.78 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 41.47 43.82 54.87
Gross Margin - 5 Yr. Avg. -- 55.59 52.44
EBITD Margin (TTM) -54.91 -- --
EBITD - 5 Yr. Avg -1,199.43 -215.54 15.70
Operating Margin (TTM) -77.09 -635.70 6.77
Operating Margin - 5 Yr. Avg. -1,083.28 -232.57 11.08
Pre-Tax Margin (TTM) -106.74 -605.50 7.60
Pre-Tax Margin - 5 Yr. Avg. -1,112.36 -232.71 11.49
Net Profit Margin (TTM) -107.92 -603.22 3.83
Net Profit Margin - 5 Yr. Avg. -1,090.22 -236.06 7.78
Effective Tax Rate (TTM) -- 15.54 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.17 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 693,890 22,216,302 857,902,259
Net Income/Employee (TTM) -748,847 -2,116,531 100,310,105
Receivable Turnover (TTM) 15.39 26.19 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.46 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.09 -9.39 11.35
Return on Assets - 5 Yr. Avg. -11.53 0.13 12.32
Return on Investment (TTM) -62.12 -11.69 14.48
Return on Investment - 5 Yr. Avg. -12.39 3.37 16.13
Return on Equity (TTM) -216.13 -36.44 16.06
Return on Equity - 5 Yr. Avg. -13.75 5.73 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -112.47 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novelion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -31.39 -33.11 5 96
13 Week -50.72 -53.63 6 74
26 Week -63.99 -66.97 4 59
52 Week -61.47 -67.26 10 62
YTD -59.50 -65.81 10 52
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 81.08%
# of Holders: 103
Total Shares Held: 15,122,655
3 Mo. Net Change: -872,766
# New Positions: 8
# Closed Positions: 12
# Increased Positions: 32
# Reduced Positions: 37
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.